Lexicon Pharmaceuticals said that it will lay off 60% of its staff and eliminate its commercial operations as part of a broader restructuring effort.
The biopharmaceutical company said Friday that the decisions are part of an effort to preserve its cash and focus its resources on advancing its clinical development pipeline.
https://www.marketwatch.com/story/lexicon-pharmaceuticals-to-slash-60-of-jobs-close-commercial-operations-as-part-of-reorganization-9728eebb